![Einat Zisman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Einat Zisman
Direktor/Vorstandsmitglied bei
Plantylight Ltd.
Profil
Einat Zisman is currently a Director at Plantylight Ltd. She previously served as President & CEO at Hadasit Medical Research Services & Development Ltd. and as CEO & Director at FutuRx Ltd. She also held director positions at HBL- Hadasit Bio-Holdings Ltd., SciSparc Ltd., ProtAb Ltd., Enlivex Therapeutics Ltd., KAHR Medical Ltd., Bio-MarCare Technologies Ltd., and was Chief Business Officer at Yeda Research & Development Co. Ltd. Zisman holds an MBA from the University of Southern California, an undergraduate degree from The Hebrew University of Jerusalem, a graduate degree from Ben-Gurion University of the Negev, and a doctorate from the Weizmann Institute of Science.
Aktive Positionen von Einat Zisman
| Unternehmen | Position | Beginn |
|---|---|---|
Plantylight Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Einat Zisman
| Unternehmen | Position | Ende |
|---|---|---|
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Vorstandsvorsitzender | 01.01.2018 |
ProtAb Ltd.
 ProtAb Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents that modulate cytokine regulation and tipping the balance toward anti-inflammatory signaling pathways | Direktor/Vorstandsmitglied | - |
| HBL - HADASIT BIO-HOLDINGS LTD | Direktor/Vorstandsmitglied | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Direktor/Vorstandsmitglied | - |
Yeda Research & Development Co. Ltd.
 Yeda Research & Development Co. Ltd. Investment ManagersFinance Initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by Weizmann Institute of Science | Corporate Officer/Principal | - |
Ausbildung von Einat Zisman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
HBL- Hadasit Bio-Holdings Ltd.
 HBL- Hadasit Bio-Holdings Ltd. Investment ManagersFinance Provides investment services in research and development companies for the medical & biotechnology sectors | Finance |
SciSparc Ltd.
 SciSparc Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative vaccines and immunotherapy products | Health Technology |
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents that modulate cytokine regulation and tipping the balance toward anti-inflammatory signaling pathways | Health Technology |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Yeda Research & Development Co. Ltd.
Yeda Research & Development Co. Ltd. Investment ManagersFinance Initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by Weizmann Institute of Science | Finance |
Bio-MarCare Technologies Ltd.
 Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance | Health Services |
Plantylight Ltd. | |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
